Modulation of D2R-NR2B interactions in response to cocaine

被引:197
作者
Liu, Xian-Yu
Chu, Xiang-Ping
Mao, Li-Min
Wang, Min
Lan, Hong-Xiang
Li, Ming-Hua
Zhang, Guo-Chi
Parelkar, Nikhil K.
Fibuch, Eugene E.
Haines, Michelle
Neve, Kim A.
Liu, Fang
Xiong, Zhi-Gang
Wang, John Q. [1 ]
机构
[1] Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Anesthesiol, Sch Med, Kansas City, MO 64108 USA
[3] Robert S Dow Neurobiol Labs, Portland, OR 97232 USA
[4] Univ Toronto, Dept Neurosci, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada
[5] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA
[6] Vet Affairs Med Ctr, Portland, OR 97239 USA
关键词
D O I
10.1016/j.neuron.2006.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine-glutamate interactions in the neostriatum determine psychostimulant action, but the underlying molecular mechanisms remain elusive. Here we found that dopamine stimulation by cocaine enhances a heteroreceptor complex formation between dopamine D2 receptors (D2R) and NMDA receptor NR2B subunits in the neostriatum in vivo. The D2R-NR2B interaction is direct and occurs in the confined postsynaptic density microdomain of excitatory synapses. The enhanced D2R-NR2B interaction disrupts the association of Ca2+/ calmodulin-dependent protein kinase H (CaMKII) with NR2B, reduces NR2B phosphorylation at a CaMKII-sensitive site (Ser1303), and inhibits NMDA receptor-mediated currents in medium-sized striatal neurons. Furthermore, the regulated D2R-NR2B interaction is critical for constructing behavioral responsiveness to cocaine. Our findings here uncover a direct and dynamic D2R-NR2B interaction in striatal neurons in vivo. This type of dopamine-glutamate integration at the receptor level may be responsible for synergistically inhibiting the D2R-mediated circuits in the basal ganglia and fulfilling the stimulative effect of psychostimulants.
引用
收藏
页码:897 / 909
页数:13
相关论文
共 64 条
[1]   Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons [J].
Aizman, O ;
Brismar, H ;
Uhlén, P ;
Zettergren, E ;
Levey, AI ;
Forssberg, H ;
Greengard, P ;
Aperia, A .
NATURE NEUROSCIENCE, 2000, 3 (03) :226-230
[2]   5-phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition [J].
Auberson, YP ;
Allgeier, H ;
Bischoff, S ;
Lingenhoehl, K ;
Moretti, R ;
Schmutz, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) :1099-1102
[3]   Addiction, dopamine, and the molecular mechanisms of memory [J].
Berke, JD ;
Hyman, SE .
NEURON, 2000, 25 (03) :515-532
[4]   Decoding dopamine signaling [J].
Bibb, JA .
CELL, 2005, 122 (02) :153-155
[5]   Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch [J].
Bofill-Cardona, E ;
Kudlacek, O ;
Yang, Q ;
Ahorn, H ;
Freissmuth, M ;
Nanoff, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32672-32680
[6]   Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus Accumbens [J].
Boudreau, AC ;
Wolf, ME .
JOURNAL OF NEUROSCIENCE, 2005, 25 (40) :9144-9151
[7]   Characterization of a calmodulin kinase II inhibitor protein in brain [J].
Chang, BH ;
Mukherji, S ;
Soderling, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10890-10895
[8]   A new type of amido-substituted p-tert-butylcalix[6]arene:: Double diamide bridges on the lower rim [J].
Chen, YK ;
Chen, YY .
ORGANIC LETTERS, 2000, 2 (06) :743-745
[9]   Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand [J].
Chung, HJ ;
Huang, YH ;
Lau, LF ;
Huganir, RL .
JOURNAL OF NEUROSCIENCE, 2004, 24 (45) :10248-10259
[10]   Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32 [J].
Dunah, AW ;
Sirianni, AC ;
Fienberg, AA ;
Bastia, E ;
Schwarzschild, MA ;
Standaert, DG .
MOLECULAR PHARMACOLOGY, 2004, 65 (01) :121-129